Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10813984
APP PUB NO 20150306198A1
SERIAL NO

14696207

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a peptide-based immunotherapy for ASPH-expressing tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RHODE ISLAND HOSPITAL593 EDDY STREET PROVIDENCE RI 02903

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wands, Jack R East Greenwich, US 81 1293

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 27, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 27, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00